Molnumize 200mg Capsule
Molnupiravir (200mg)
by Torrent Pharmaceuticals Ltd
strip of 10 capsules
About this medicine
Molnumize 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.Molnumize 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molnumize 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molnumize 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molnumize 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Uses
- Treatment of Mild to moderate Coronavirus disease (COVID-19)
Benefits
In Treatment of Mild to moderate Coronavirus disease (COVID-19) Molnumize 200mg Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration. This medicine may help you recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.
How it works
Molnumize 200mg Capsule is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.
How to use
Take this medicine in the dose and duration as advised by your doctor. Molnumize 200mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Common side effects
- Nausea
- Dizziness
- Diarrhea
Safety advice
- AlcoholCONSULT YOUR DOCTOR
- It is not known whether it is safe to consume alcohol with Molnumize 200mg Capsule. Please consult your doctor.
- PregnancyCONSULT YOUR DOCTOR
- Molnumize 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
- Breast feedingUNSAFE
- Molnumize 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
- DrivingCONSULT YOUR DOCTOR
- It is not known whether Molnumize 200mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
- KidneySAFE IF PRESCRIBED
- Molnumize 200mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Molnumize 200mg Capsule is recommended.
- LiverSAFE IF PRESCRIBED
- Molnumize 200mg Capsule is safe to use in patients with liver disease. No dose adjustment of Molnumize 200mg Capsule is recommended.
If you miss a dose
If you miss a dose of Molnumize 200mg Capsule, please consult your doctor.
Quick facts
- Chemical Class
- Cytosine Nucleotides
- Habit Forming
- No
- Therapeutic Class
- Anti infectives
- Action Class
- Antiviral (Non-HIV) drugs
Frequently asked questions
Can Molnumize 200mg Capsule be given to children?
No, Molnumize 200mg Capsule is not approved for use in children or patients below the age of 18 years as it may interfere with the growth of bones and cartilage.
What is the advantage of using Molnumize 200mg Capsule?
Molnumize 200mg Capsule has better patient compliance than some other treatment options available against COVID-19. Unlike other medicines that may need a skilled healthcare professional (a doctor or a nurse) to administer, Molnumize 200mg Capsule is an oral medicine that can be consumed by mouth in the dosage and schedule prescribed by the doctor.
Are there any serious risks of taking Molnumize 200mg Capsule?
Yes, there are some serious risks involved with using Molnumize 200mg Capsule, including its potential to cause birth defects in pregnant women and serious damage to the growth of bones and cartilage (which may cause serious muscle damage). Therefore, Molnumize 200mg Capsule should be used only if prescribed by a doctor and not used for self-medication.
Is taking Molnumize 200mg Capsule better than getting vaccinated?
No. There is no comparison between the two, and Molnumize 200mg Capsule is not a substitute for getting vaccinated. Vaccination is for prevention, while Molnumize 200mg Capsule is used to treat an existing COVID-19 infection, provided the infection is diagnosed at an early stage.
Who is at a high risk of developing severe COVID-19?
People who are at a high risk of developing severe COVID-19 include those aged above 60 years, who are obese, have comorbid conditions including high blood pressure, diabetes, asthma, other medical conditions related to the lungs, kidneys (like dialysis patients), liver, or those who have a weak immunity (like cancer patients).
Who should not take Molnumize 200mg Capsule?
Molnumize 200mg Capsule should not be taken to prevent COVID-19 or treat patients hospitalized due to COVID-19. According to the ongoing clinical trials, patients hospitalized with severe COVID-19 infection have not benefited from taking Molnumize 200mg Capsule.
Product details
- Manufacturer
- Torrent Pharmaceuticals Ltd
- Salt composition
- Molnupiravir (200mg)
- Pack
- strip of 10 capsules
- Dosage form
- Tablet
The content above is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a registered medical practitioner before starting, stopping or changing any medicine.